Hepatitis B virus infection in Chinese families in Hong Kong.
about
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxisPrognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation?Update on diagnosis, management, and prevention of hepatitis B virus infection.Risk factors for intrafamilial spread of hepatitis B in northeastern Bosnia and Herzegovina.Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity.Intrafamilial transmission of hepatitis C virus: a systematic review.Horizontal transmission of hepatitis B virus in children with chronic hepatitis B.Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B.Hepatitis B virus infection among Chinese residents in the United KingdomRisk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral ProphylaxisFulminant hepatitis following chemotherapy treatment for breast cancerHepatitis B immunization strategies: timing is everythingThe Association between Female Genital Cutting and Spousal HCV Infection in Egypt.Intra-familial spread of hepatitis B virus infection in eastern Turkey.Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population.Rituximab administration and reactivation of HBV.Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population.Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus.Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy.Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.History and prevention of de novo hepatitis B virus-related hepatitis in Japan and the world.Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic.The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.Diabetes Mellitus and Risk of Hepatocellular Carcinoma.Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong.A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.Mortality mapping in Hong Kong, 1979-83 and 1984-88: feasibility study and the patterns of cancers.
P2860
Q28348802-2923D05B-565A-4F44-A5B9-6089550A6E9AQ31152723-5F2FFC80-14BD-477A-BBD1-C4BBA81030E4Q33336993-6283C889-E457-4E1D-AFD9-25F09CA6F769Q33588921-6A5FF242-76A9-49D2-8862-A25E1C6DF93DQ33619496-EA8E08E9-3958-4DAD-A9E1-D99DA7B22506Q33705615-C4DC9BCB-D14C-417D-A94A-AA21A7A79524Q33888824-A9DB3DCE-D684-4026-82D4-013859194335Q34382347-E610346C-51DD-4925-B765-42DA9BCD13DCQ34394777-926FF403-F48C-496B-AAE2-C834F3C7C906Q34627978-EF441C08-3FB9-4246-823C-3ECC9FB2BB0EQ34725898-0EAD6410-D8AD-4F6E-8562-E1DFCFE46E0FQ35529989-41621F2F-9D28-4B04-8EB8-BD7C44A24258Q35746079-2407CC4C-E3C1-4D8D-8E78-037A3FC3ECD9Q36704509-98A55877-8E4E-4E0E-B47B-267B5FAD517FQ37052559-37C7A81E-5B41-4221-82FB-BF9749AF20D3Q37693859-A10429C2-0F81-4341-8DFB-4C4A4FCEA423Q40240656-A8C5FEF0-DD7E-48AE-93C7-57A0BA3DDBC9Q40551445-9376DB33-B25A-4165-B210-82E515ACFE5BQ41215683-31EDF18C-CE7A-4699-8382-8E3067614ED3Q41657906-ED67B637-89FF-4310-B98B-5291FB2E9E2EQ41815804-ABBFCA43-1A58-4918-8C52-0E939F2E356FQ42121505-1BCE61EE-4E90-4771-872E-80B55081DFFBQ43471901-569D2E43-A2C4-4D4B-9B87-3E7CE78FB89AQ45341288-14523D4C-98DD-4ADD-9DB5-AE2B9AAB6AC3Q45355599-1C27DE5F-0E78-4F61-B14E-00C70575368BQ45366697-90A36015-69A3-4811-8DA9-64BC346397E5Q48146168-8F66328A-D4A8-4E60-B5FB-2F84B2D9F6B7Q50889232-CFB2F310-28FE-4D4A-82AB-434D17E23B24Q50914463-58BDFE77-71C0-453E-B208-79DB87FE6948Q50973109-0C17C899-F02F-499A-85AD-8CAF76D731AD
P2860
Hepatitis B virus infection in Chinese families in Hong Kong.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Hepatitis B virus infection in Chinese families in Hong Kong.
@en
Hepatitis B virus infection in Chinese families in Hong Kong.
@nl
type
label
Hepatitis B virus infection in Chinese families in Hong Kong.
@en
Hepatitis B virus infection in Chinese families in Hong Kong.
@nl
prefLabel
Hepatitis B virus infection in Chinese families in Hong Kong.
@en
Hepatitis B virus infection in Chinese families in Hong Kong.
@nl
P2093
P1476
Hepatitis B virus infection in Chinese families in Hong Kong
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.AJE.A114681
P407
P577
1987-09-01T00:00:00Z